The US bioeconomy is worth $950 billion, and growing, thanks to these federal policies

Biotechnology — or the use of technology to convert plant and biological material into commodities — is not new.  Doug Friedman, CEO of BioMADE, the Bioindustrial Manufacturing Innovation Institute, and…

Continue ReadingThe US bioeconomy is worth $950 billion, and growing, thanks to these federal policies

‘The pace of growth is breaking us’: Utilities, corporations grapple with grid decarbonization

Under pressure from regulators, investors and customers, dozens of U.S. corporations have set ambitious net-zero carbon targets for their operations and their suppliers. At the same time, decarbonizing the power…

Continue Reading‘The pace of growth is breaking us’: Utilities, corporations grapple with grid decarbonization